33 Results

People

  1. Maloy
    Maloy
  2. Sauter
    Sauter
  3. Perales
    Perales
  4. Shah
    Shah
  5. Devlin
    Devlin
  6. Dahi
    Dahi
  7. Giralt
    Giralt
  8. Scordo
    Scordo
  9. Palomba
    Palomba
  10. Batlevi
    Batlevi

Groups

  1. Center for Hematologic Malignancies (33)
  2. Department of Medicine (33)
  3. DigITs Research Group (33)
  4. Hematologic Malignancies, Division of (33)
  5. Lymphoma (33)
  6. Biostatistics Service (29)
  7. Bone Marrow Transplant (29)
  8. Epidemiology and Biostatistics (29)
  9. Survivorship Research (29)
  10. CTCR Scholars (26)
  1. "Center for Hematologic Malignancies"
  2. "DigITs Research Group"
  3. "Lymphoma"
Formats
  1. Meeting Abstract (17)
  2. Journal Article (14)
  3. Research Letter (2)
Groups
  1. Center for Hematologic Malignancies (33)
  2. Department of Medicine (33)
  3. DigITs Research Group (33)
  4. Hematologic Malignancies, Division of (33)
  5. Lymphoma (33)
  6. Biostatistics Service (29)

More Groups

People
  1. Craig Sauter (28)
  2. Molly Maloy (28)
  3. Miguel-Angel Perales (27)
  4. Gunjan Shah (25)
  5. Sean Devlin (24)
  6. Michael Scordo (23)

More People

Years
  1. 2023 (1)
  2. 2021 (5)
  3. 2020 (11)
  4. 2019 (7)
  5. 2018 (3)
  6. 2017 (1)

More Years

Publications
  1. Biology of Blood and Marrow Transplantation (9)
  2. Blood (8)
  3. Blood Advances (6)
  4. Bone Marrow Transplantation (2)
  5. Haematologica (2)
  6. Blood Cancer Journal (1)

More Publications

Publishers
  1. American Society of Hematology (14)
  2. Elsevier Inc. (10)
  3. Nature Publishing Group (4)
  4. Ferrata Storti Foundation (2)
  5. Cell Press (1)
  6. Impact Journals (1)

More Publishers

Results (33)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Predictors of SARS-CoV-2 Omicron breakthrough infection after receipt of AZD7442 (tixagevimab-cilgavimab) for pre-exposure prophylaxis among hematologic malignancy patients
    Journal Article

    Laracy, J. C.; Yan, J.; Steiger, S. N.; Tan, C. A.; Cohen, N.; Robilotti, E. V.; Fender, J.; Cohen, S.; Korde, N.; Lee-Teh, M.; more...
    Haematologica (2023)

    Fulltext@MSK | Save
  • Modified EASIX predicts severe cytokine release syndrome and neurotoxicity after chimeric antigen receptor T cells
    Journal Article

    Pennisi, M.; Sanchez-Escamilla, M.; Flynn, J. R.; Shouval, R.; Alarcon Tomas, A.; Silverberg, M. L.; Batlevi, C.; Brentjens, R. J.; Dahi, P. B.; Devlin, S. M.; more...
    Blood Advances (2021)

    Fulltext@MSK | Save
  • Reduced-intensity conditioning hematopoietic stem cell transplantation for chronic lymphocytic leukemia and Richter's transformation
    Journal Article

    Lahoud, O. B.; Devlin, S. M.; Maloy, M. A.; Roeker, L. E.; Dahi, P. B.; Ponce, D. M.; Gyurkocza, B.; Koehne, G.; Young, J. W.; Castro-Malaspina, H. R.; more...
    Blood Advances (2021)

    Fulltext@MSK | Save
  • Toxicities of high-dose chemotherapy and autologous hematopoietic cell transplantation in older patients with lymphoma
    Journal Article

    Dahi, P. B.; Lee, J.; Devlin, S. M.; Ruiz, J.; Maloy, M.; Rondon-Clavo, C.; Petrlik, E.; Tamari, R.; Shah, G.; Scordo, M.; more...
    Blood Advances (2021)

    Fulltext@MSK | Save
  • The International Prognostic Index is associated with outcomes in diffuse large B cell lymphoma after chimeric antigen receptor T cell therapy
    Journal Article

    Garcia-Recio, M.; Wudhikarn, K.; Pennisi, M.; Alonso-Trillo, R.; Flynn, J.; Shouval, R.; Afuye, A. O.; Silverberg, M. L.; Batlevi, C. W.; Dahi, P.; more...
    Transplantation and Cellular Therapy (2021)

    Fulltext@MSK | Save
  • Impact and safety of chimeric antigen receptor T-cell therapy in older, vulnerable patients with relapsed/refractory large B-cell lymphoma
    Research Letter

    Lin, R. J.; Lobaugh, S. M.; Pennisi, M.; Chan, H. T.; Batlevi, Y.; Ruiz, J. D.; Elko, T. A.; Maloy, M. A.; Batlevi, C. L.; Dahi, P. B.; more...
    Haematologica (2021)

    Fulltext@MSK | Save
  • International prognostic index predicts outcomes in patients with relapsed and refractory large diffuse B cell lymphoma treated with commercial CAR T cells
    Meeting Abstract

    Garcia-Recio, M.; Wudhikarn, K.; Pennisi, M.; Alonso-Trillo, R.; Flynn, J.; Roni, S.; Batlevi, Y.; Silverberg, M. L.; Batlevi, C. W.; Brentjens, R.; more...
    Bone Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Impact of allogeneic hematopoietic cell transplantation on immune evasive mechanisms in relapsed refractory large B-cell lymphoma
    Research Letter

    Lin, R. J.; Ho, C.; Devlin, S. M.; Ruiz, J. D.; Maloy, M. A.; Shah, G. L.; Perales, M. A.; Dahi, P. B.; Giralt, S. A.; Scordo, M.; more...
    Bone Marrow Transplantation (2020)

    Fulltext@MSK | Save
  • Hematopoietic recovery in patients receiving chimeric antigen receptor T-cell therapy for hematologic malignancies
    Journal Article

    Jain, T.; Knezevic, A.; Pennisi, M.; Chen, Y.; Ruiz, J. D.; Purdon, T. J.; Devlin, S. M.; Smith, M.; Shah, G. L.; Halton, E.; more...
    Blood Advances (2020)

    Fulltext@MSK | Save
  • The geriatric syndrome of sarcopenia impacts allogeneic hematopoietic cell transplantation outcomes in older lymphoma patients
    Journal Article

    Lin, R. J.; Michaud, L.; Lobaugh, S. M.; Nakajima, R.; Mauguen, A.; Elko, T. A.; Ruiz, J. D.; Maloy, M. A.; Sauter, C. S.; Dahi, P. B.; more...
    Leukemia and Lymphoma (2020)

    Fulltext@MSK | Save